Pharmacogenomics: challenges and opportunities

被引：12
|
作者：
Peet, NP [1 ]
Bey, P [1 ]
机构：
[1] ArQule, Drug Discovery, Parallel Track, Woburn, MA 01801 USA
来源：
DRUG DISCOVERY TODAY | 2001年 / 6卷 / 10期
关键词：
D O I：
10.1016/S1359-6446(01)01761-5
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：495 / 498
页数：4
相关论文
共 50 条
  • [1] Pharmacogenomics: Challenges and opportunities
    Roden, Dan M.
    Altman, Russ B.
    Benowitz, Neal L.
    Flockhart, David A.
    Giacomini, Kathleen M.
    Johnson, Julie A.
    Krauss, Ronald M.
    McLeod, Howard L.
    Ratain, Mark J.
    Relling, Mary V.
    Ring, Huijun Z.
    Shuldiner, Alan R.
    Weinshilboum, Richard M.
    Weiss, Scott T.
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 145 (10) : 749 - 757
  • [2] Challenges and opportunities in pharmacogenomics and therapeutics
    Kane, Michael D.
    Summers, Kent H.
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (07): : 607 - 608
  • [3] Challenges and opportunities in ADHD pharmacogenomics
    Kieling, Christian
    Rohde, Luis Augusto
    [J]. PHARMACOGENOMICS, 2008, 9 (09) : 1193 - 1194
  • [4] Economic Opportunities and Challenges for Pharmacogenomics
    Deverka, Patricia A.
    Vernon, John
    McLeod, Howard L.
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2010, 50 : 423 - 437
  • [5] RECENT TRENDS IN CHALLENGES AND OPPORTUNITIES OF PHARMACOGENOMICS
    Bhowmik, Debjit
    Chiranjib
    Das, B. C.
    Kumar, K. P. Sampath
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2010, 1 (08): : 37 - 46
  • [6] Pharmacogenomics at the Tipping Point: Challenges and Opportunities
    Roden, D. M.
    Tyndale, R. F.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (03) : 323 - 327
  • [7] Pharmacogenomics in Lebanon: current status, challenges and opportunities
    Chidiac, Lorenzo
    Yazbeck, Hady
    Mahfouz, Rami
    Zgheib, Nathalie K.
    [J]. PHARMACOGENOMICS JOURNAL, 2024, 24 (03):
  • [8] Clinical Pharmacogenomics: Opportunities and Challenges at Point of Care
    Scott, S. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (01) : 33 - 35
  • [9] Challenges and opportunities in implementing pharmacogenomics testing in the clinics
    Wisler, Jon R.
    Wisler, James W.
    Bansal, Shelly
    Marsh, Clay B.
    [J]. PERSONALIZED MEDICINE, 2012, 9 (06) : 609 - 619
  • [10] Pharmacogenomics of MDD as a Developing Field: Challenges and Opportunities
    Baune, B.
    [J]. EUROPEAN PSYCHIATRY, 2022, 65 : S39 - S39
12345